EMIS Group PLC Acquisition Timetable Update (8082E)
01 Novembre 2022 - 8:00AM
UK Regulatory
TIDMEMIS TIDM0R0O
RNS Number : 8082E
EMIS Group PLC
01 November 2022
1 November 2022
EMIS Group plc
("EMIS" or "the Group")
Acquisition Timetable Update
Acquisition Timetable Update
On 17 June 2022, the Boards of Bidco and EMIS announced that
they had reached agreement on the terms of a recommended all cash
offer pursuant to which Bidco, an affiliate of Optum UK and a
wholly-owned subsidiary of UnitedHealth Group, will acquire the
entire issued and to be issued ordinary share capital of EMIS (the
"Acquisition"). The Acquisition is being implemented by means of a
Court-sanctioned scheme of arrangement under Part 26 of the
Companies Act 2006 (the "Scheme").
On 9 August 2022, EMIS announced that at the Court Meeting to
consider the Scheme and the General Meeting to consider the Special
Resolution relating to the Acquisition, all resolutions were
approved by the requisite majorities. EMIS further announced that a
notification had been made and accepted under the NS&I Act and
that the Secretary of State had confirmed that no further action
will be taken in relation to the Acquisition.
As regards the remaining substantive regulatory condition to the
Acquisition, Bidco and EMIS are in the process of finalising a
Merger Notice with the Competition and Markets Authority ("CMA"),
preliminary to a Phase One investigation of the Acquisition. As a
result, unless the relevant condition is waived by Bidco, EMIS now
expects the Scheme to become Effective in the first quarter of
2023.
Unless otherwise defined, all capitalised terms in this
announcement shall have the same meaning given to them in the
Scheme Document.
For further information, contact:
EMIS Group plc Tel: 0330 024 1269
Andy Thorburn, CEO
Peter Southby, CFO
www.emisgroupplc.com
@EMISGroup
Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000
Joshua Hughes/Simon Willis/James Black
MHP Communications Tel: 020 3128 8567
Reg Hoare/ Ollie Hoare/ Matthew Taylor/Pauline Guenot emis@mhpc.com
Information for investors can be found on the Group's website at
www.emisgroupplc.com/investors .
Notes to Editors
EMIS Group has grown to become a UK leader in connected
healthcare software and systems. Its solutions are widely used
across a number of major UK healthcare settings. EMIS Group's aim
is to join up healthcare through innovative technology, helping to
deliver better health outcomes to the UK population, supporting
longer and healthier lives.
EMIS Group has two core business segments: EMIS Health and EMIS
Enterprise.
EMIS Health is a supplier of innovative integrated care
technology to the NHS, including primary, community, acute and
social care.
EMIS Enterprise is focussed on growth in the
business-to-business technology sector within the healthcare
market, including management of medicines, partner businesses,
patient-facing services, data and analytics, and research and life
sciences.
LEI: 213800K474ZZK76NX913
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
OUPBKDBQOBDDOKN
(END) Dow Jones Newswires
November 01, 2022 03:00 ET (07:00 GMT)
Grafico Azioni Unitedhealth (LSE:0R0O)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Unitedhealth (LSE:0R0O)
Storico
Da Mar 2024 a Mar 2025